Safety, Tolerability, Pharmacokinetics of Intravenous FL058 and Meropenem in Healthy Subjects(SAD/MAD)
Clinical trial NCT05058105 · COMPLETED
Trial details
- NCT number
- NCT05058105
- Sponsor
- Qilu Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-08
- Primary completion
- 2021-02-24
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.